Thoracic Oncologist in OKC @IntegrisHealth | Fellowship @theNCI | Residency @MayoClinic | Clinical Trials | Terrible Golfer | Views/tweets are my own
Joined March 2019
- Tweets517
- Following635
- Followers612
- Likes1.2K
From screaming at the top of my lungs last night (@threedaysgrace ), to screening lungs today at @integrishealth lung cancer awareness and screening!
13
391
Clay Reed, MD retweeted
Excited to see @Falah_Fayaz trajectory who’s been working with me @OUCollegeofMed for a year now applying for match27. Falah is a valedictorian from @GMCSrinagar , has worked on clinical and translational projects including on ADC Tox . ⭐️ candidate for any program ! @Ayeshaaijaz
Submitted my ERAS application! #Match2027 🩺
From Kashmir to the States, this journey has been exciting! It's been a privilege to be able to pursue my passion for research at @StephensonCC working on immunotherapy toxicity and precision oncology.
Grateful to @thenasheffect for his mentorship, and to the amazing people I've been fortunate to work with, @Ayeshaaijaz and @HMAbushukhair
Excited for the next chapter!
#MedTwitter #IMG
AAMC ID: 16736659
Such a great time with these phenomenal fellows. Was honored to be the only community thoracic oncologist to provide a unique perspective. @integrishealth @OncLive
Thank you fellows, faculty, and OncLive for an outstanding day of learning, collaboration, and networking. Inspiring discussions, new connections, and a shared commitment to advancing care. The future is bright! @OncLive @StephenVLiu @drshieldsmd @PatelOncology
4
383
Spent over 40 minutes on the phone with a patient’s insurance because they denied her chemoIO because they misread the note for “small cell” instead of “non-small cell carcinoma”. They then realized this mistake on their end (after I pointed this out), but they couldn’t resolve it without a peer to peer.. which can’t happen until next week
132
Clay Reed, MD retweeted
🫁 𝟮𝟬 𝗣𝗼𝘀𝘁𝘀 𝗬𝗼𝘂 𝗦𝗵𝗼𝘂𝗹𝗱𝗻’𝘁 𝗠𝗶𝘀𝘀 𝗙𝗿𝗼𝗺 𝗧𝗲𝘅𝗮𝘀 𝗟𝘂𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝟮𝟬𝟮𝟲
OncoDaily Lung followed the key conversations from Texas Lung Cancer Conference 2026 and gathered 20 standout posts from experts across thoracic oncology.
🔹 What stood out
• Important clinical debates
• New research perspectives
• Expert insights from leading voices
• Real discussions shaping lung cancer care
🔬 From stage III NSCLC and adjuvant therapy updates to small cell lung cancer and multidisciplinary decision-making, this meeting reflected where the field is moving next.
📌 𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝘁𝗵𝗲 𝗽𝗼𝘀𝘁𝘀 𝗳𝗲𝗮𝘁𝘂𝗿𝗲𝗱 𝗯𝘆 𝗢𝗻𝗰𝗼𝗗𝗮𝗶𝗹𝘆 𝗟𝘂𝗻𝗴.
oncodaily.com/not-to-miss/te…
@DrewMoghanaki @JoeChangMD @heidi_onda @BenCreelan @lungoncdoc @jennifermarksmd @NarjustFlorezMD @chulkimMD @BalazsHalmosMD @ipreeshagul @KCargillMDPhD @ClayReedMD @yajur_arya @Latinamd @StephenVLiu @drshieldsmd
#LungCancer #TLC #NSCLC #OncoDaily #Oncology #cancer
More like Brendon “Styles”
@BrendonStilesMD
@TLCconference Texas Lung Hold 'Em Debate: Surgical vs Non-surgical Approaches to Early-Stage Lung Cancer
#TexasLung26
Laura Linney powerfully capping off a phenomenal day @TLCconference. Physicians, researchers, industry, patients, and others coming together to advance lung cancer care for our patients #TexasLung26
The mighty @thenasheffect delivering a phenomenal talk on SCLC and tarlatamab. Another @NIH alumni in okc here at @binaytara #OKTO26!
Clay Reed, MD retweeted
ADCs are reshaping the Tx landscape in NSCLC
• Activity across multiple targets (HER2, MET, TROP2)
• Variable correlation between target expression and efficacy
Can ADCs replace docetaxel in 2L?
Yes - but better target selection & ADC design needed.
@FawziAbuRous #OKTO26
A mighty debate about the utility of ctDNA between @aadel_chaudhuri and @AminNassarMD at the @binaytara 2026 OK Thoracic oncology conference. Awesome (and entertaining debate)
Looking forward to an amazing thoracic oncology conference tomorrow in OKC with @binaytara. We have phenomenal speakers from across the country coming to OKC!
9
251
Clay Reed, MD retweeted
We now have 3 options for Her2+ NSCLC! TDXd is approved for Her2 mutated (Her2 IHC3+ given bucket approval). Sevabertinib and Zongertinib approved for Her2 mutated disease only!
#lcsm #OncTwitter #MedTwitter
Sevabertinib (oral TKI) now @US_FDA ✅ based off #SOHO01 in previously treated mNSCLC w/ HER2+:
- ORR 60% w/ disease control in 84%
- AEs includied diarrheaby but no pneumonitis
- We now have TDxD, Zongertinib, and Sevabertinib
#OncTwitter #MedTwitter @herbloong @LeXiuning
Super excited to announce our formation of a stellar thoracic oncology team at @integrishealth in OKC. The first community hospital in the region offering sub-specialized oncology care from docs trained at some of the best hospitals in the nation!
Clay Reed, MD retweeted
Golf golf golf golf golf golf golf golf golf golf golf golf (attempting to reset my timeline) golf golf golf golf golf golf golf golf golf golf golf golf golf golf golf golf
I try to stay mostly apolitical. But if one party constantly demonizes another by calling them “threat to democracy” “threats to the nation” comparing them to “dictators” and “Nazis”- how can you be surprised when insane people are continuously trying to assassinate their political enemies. Horrible and tragic.. pray for @charliekirk11
One of the craziest stories I had never heard of (in my home city nonetheless). In 1963 an elephant died from LSD overdose at the OKC zoo during the medical research of LSD. #RipTusko guinnessworldrecords.com/new… via @GWR
Hot take: If an oncologist calls a quite toxic regimen (such as Amivantimab plus Lazertinib) a “chemo free alternative” to patients - that is extremely disingenuous. Patients do not care about the semantics. They should know the regimen is toxic. “Chemo free” is misleading
Was fortunate to see @OzzyOsbourne back in 2017. Even at 68, he put on the best show I’ve ever seen
1
7
483